Table 4.
URTI (n:1926) | LRTI (n:681) | Asthma (n:317) | Systemic symptoms (n:3197) | p | |
---|---|---|---|---|---|
PIV 1 | 34 (1.77%) | 8 (1.17%) | 4 (1.26%) | 41 (1.28%) | ns |
PIV 2 | 2 (0.1%) | 1 (0.15%) | 1 (0.32%) | 3 (0.09%) | ns |
PIV 3 | 39 (2.02%) | 10 (1.47%) | 3 (0.95%) | 31 (0.97%) | ns |
PIV 4 | 14 (0.73%) | 7 (1.03%) | 1 (0.32%) | 16 (0.5%) | ns |
PIV NT | 14 (0.73%) | 8 (1.17%) | 3 (0.95%) | 28 (0.87%) | ns |
Total PIV | 103 (5.35%) | 34 (4.99%) | 12 (3.78%) | 119 (3.72%) | ns |
VL | 5.35 ± 1.17 (3.1–9.5) | 5.1 ± 1.2 (2.9–7.6) | 5.33 ± 1.3 (2.9–7.9) | 5.38 ± 1.19 (2.4–8.4) | ns |
VL viral load (log10) copies/103 cells, NT not typed